CLINICAL_TRIALS
trial_result
· 2012-05-23
Clinical Trial Update: A Study Of PF-05190457 In Healthy Volunteers And Type-2 Diabetic Patients [Phase 1]
Summary
A Phase 1 study evaluating PF-05190457 in healthy volunteers and individuals with Type 2 diabetes has been terminated.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Pfizer | Conditions: Diabetes Mellitus, Type 2 | Phase 1 | Status: TERMINATED